Hydrocortisone Ointment Recalled Due to Temperature Exposure During Distribution
McKesson Medical-Surgical is recalling Hydrocortisone Ointment USP 2.5% nationwide due to temperature abuse during distribution that violated manufacturing standards.
What this means for you
Minor labeling or packaging issue, or a voluntary precautionary recall. Risk of harm is low but real — follow the manufacturer's instructions.
Our severity reasoning: FDA Class II recall with no reported illnesses or injuries. The deviation is a cGMP violation (temperature abuse) with unknown clinical impact. Without documented harm or specific risk-of-harm language in the source, this fits the rubric criterion for 'low-risk contamination, voluntary precautionary recalls.'
Plain-English summary
McKesson Medical-Surgical Inc. is recalling Hydrocortisone Ointment USP 2.5% (1 oz tubes, NDC 0168-0146-30) manufactured by Sandoz Pharma and distributed nationwide.
The recall was initiated due to cGMP deviations involving temperature abuse during distribution. Temperature exposure can affect pharmaceutical product stability and quality.
The recalled product was distributed nationwide to healthcare facilities and pharmacies. McKesson is unable to identify specific lot numbers for individual consignees; each notification letter includes the distribution date and the timeframe during which affected product may have been shipped to that customer.
Consumers and healthcare providers should discontinue use of recalled Hydrocortisone Ointment and contact their pharmacy or healthcare provider for information about returns or alternative treatments.
The recalled product
- Product
- HYDROCORTISONE (HYDROCORTISONE)
- Brand
- HYDROCORTISONE
- Manufacturer
- Mckesson Medical-Surgical Inc. Corporate Office
- Category
- Drug — Topical Corticosteroid
- Hazard
- temperature-exposure
- manufacturing-defect
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
UPCs (2)
- 0301680146300
- 0301680080314
Distribution
Distributed nationwide across the United States.
Related recalls
Same category
- CriticalWarfarin Tablets Recalled After Mix-Up Between 2.5 mg and 5 mg Strengths
FDA (Drugs) · 2026-07-21
- ModerateFDA Recalls Pred Mild Ophthalmic Suspension Due to Failed Stability Specifications
FDA (Drugs) · 2026-06-03
- ModerateNicotine Transdermal System Patches Recalled for Oxidative Impurity Specification Failure
FDA (Drugs) · 2026-06-03
- ModerateGas-X Simethicone 125 mg softgels recall for incomplete labeling
FDA (Drugs) · 2026-05-27
- HighLiraglutide Injection Recalled Due to Particulate Matter in Cartridges
FDA (Drugs) · 2026-05-27